Stocks
Cerebos receives approval for delisting
SGX-ST has advised that it has no objections to the proposed delisting, subject to shareholders’ approval.
Cerebos receives approval for delisting
SGX-ST has advised that it has no objections to the proposed delisting, subject to shareholders’ approval.
STI set for flat open
Far from flat however is the ongoing APB and F&N story.
STI set for firmer open
The index however is forecast to consolidate around current levels.
STI set for weaker open
No thanks to the mild retreat on Wall Street overnight and the muted Nikkei start.
STI set for strong open
Thanks to the continued recovery by the US and European markets.
NOL sinks in STI waters
IHH Healthcare replaced Neptune Orient Lines in the Straits Times Index after a half-yearly review.
STI set for strong open
Thanks to the 1.5% rally on Wall Street overnight and the strong Nikkei start.
Stocks in focus: F&N and Genting
Thursday’s big news, says IG Markets Singapore, is ThaiBev’s new offer for Fraser and Neave.
STI locked in consolidation mode
There was significant buying interest on small to mid-cap stocks with increasing trading volume, says OCBC Investment Research.
STI drifts into negative territory
Tone is forecast to remain more downside biased, says OCBC Investment Research.
STI holds on to gains
The index had rebounded fairly strongly in the last session, opening some 0.8% higher.
STI set to end losing streak
Boost in local sentiments is expected following the sharp rebound on Wall Street and the strong Nikkei start.
STI loses 0.5%
The index continued to head further south after a 0.3% lower opening on Wednesday, says OCBC Investment Research.
STI continues dull week
The index is forecast to slide further towards the 3000 psychological base.
STI sees lackluster performance
The index hardly moved, failing to make any significant headway after opening some 0.4% lower on Monday.
18 listed firms likely to receive privatisation offers
M1 is on the list; check out other big names.
STI sees technical rebound
Gains are likely to be limited by the negative Nikkei start, says OCBC Investment Research.
Read Here
Advertise
Sign Up
